logo
The vitamin D supplement scientists say could significantly improve core autism symptoms

The vitamin D supplement scientists say could significantly improve core autism symptoms

The Sun08-07-2025
A FORM of vitamin D could significantly improve core autism symptoms, researchers claim.
Studies examining whether the common supplement could improve symptoms of autism have had inconsistent results.
But scientists from the National Research Centre in Cairo, Egypt, say a vitamin D3 nanoemulsion might help ease challenges with social interaction and restrictive or repetitive behaviours in young children.
There are at least 700,000 autistic adults and children in the UK, according to the National Autistic Society.
Autism is not an illness or disease - it influences how people experience and interact with the world.
People with the condition may find socialising confusing or tiring, and can become overwhelmed in loud or busy places.
They may have intense interests, prefer order and routine, and use repeated movements or actions to calm themselves or express joy.
Many mask their discomfort to try and fit in.
Previous research into the condition has linked autism to a lack of vitamin D - a vital nutrient the body relies on for various functions, including "brain development", the Egyptian researchers said.
Newborn babies with a vitamin D deficiency had a higher chance of developing ADHD, schizophrenia and autism, a University of Queensland study published in May found.
Earlier research from the university suggested vitamin deficiencies in mums could also play a part.
But studies looking into whether supplements could ease symptoms of autism have had mixed results.
World Autism Awareness Day: Everything you need to know
One found that giving children vitamin D3 "no influence on irritability or core autism spectrum disorder symptoms, yet it had a beneficial effect on hyperactivity", the Egyptian research team said.
"On the other hand, some studies reported improved core symptoms after supplementation with the marketed vitamin D3."
Instead of using regular vitamin D3 supplements, the new study used a nanoemulsion of vitamin D3.
It involves suspending tiny nano-sized droplets of vitamin D3 in a liquid so it can more easily absorbed used by the body.
"This study aims to investigate the influence of vitamin D3-loaded nanoemulsion supplementation on adaptive behaviour and language performance in a group of children with autism compared to the influence of the marketed product of vitamin D3," researchers wrote in LabMed Discovery.
The study involved 80 children with confirmed autism diagnoses, aged between three and six, who were randomly split into two groups.
One group took a nanoemulsion of vitamine D3 for six months, while the other group was given a commonly available standard supplement.
"The vitamin D3-loaded nanoemulsion was prepared in the pharmaceutical technology lab at the authors' institute by the pharmacists in the research team of this study," study authors noted.
What is autism?
Autism spectrum disorder (ASD) is an incurable, lifelong developmental condition that affects how people perceive the world and interact with others.
It affects around one in 100 people in the UK and is three to four times more common in boys than in girls.
Many people with ASD find it hard to understand other people's feelings and emotions, and they may have difficulty holding conversations.
When they are young, their language development may take longer and they can struggle to use facial expressions, using gestures to communicate instead.
They may also find it hard to connect with other people and to hold eye contact with unfamiliar individuals.
Many children with ASD like to follow a routine, and changes to this can cause distress.
High functioning autism is an informal term some people use to describe those on the autism spectrum disorder.
Researchers evaluated the children's vitamin D3 levels, as well social and adaptive behaviours and language development, both before and after the kids took supplements.
The children had "delays in social IQ and language abilities" when they were assessed at the start of the study.
But researchers found that the nanoemulsion raised vitamin D3 levels in the blood and seemed to significantly improve core autism symptoms.
'The supplementation of children with autism using the prepared vitamin D3-loaded nanoemulsion has led to a reduction in the severity of autism and a rise in the social IQ, especially fine motor performance and language abilities of the children with autism spectrum disorder, without adverse effects,' the researchers wrote.
The conventional supplement didn't improve autism symptoms, despite raising vitamin D3 levels in the blood.
The researchers said vitamin D3 is thought to play a role in memory, mood, behaviour and sleep regulation.
Not having enough vitamin D can disrupt the metabolism of fatty acids, which are needed for the quality and function of the membranes of cells such as neurons, they added.
"Children with autism have been reported to have gastrointestinal and sensory processing disorders, particularly those involving taste and smell, " study authors suggested.
"This makes them very prone to vitamin deficiency.
"Therefore, incorporating vitamin D3 in a nanoemulsion formulation can facilitate its absorption, its consumption at the cellular level, and its bioavailability to overcome intestinal and sensory processing disorders limiting the vitamin intake.
"This is very essential for enhancing the vitamin impact on the brain and other systems involved in adaptive behaviour."
Larger and more long-term studies are needed to confirm these findings and explore the difference in vitamin D response between girls and boys, the authors concluded.
Past research on vitamin D3 nanoemulsions has identified some concerns.
Manufacturing can be complex and expensive and the solution can become unstable.
On top of that, there is a risk of vitamin D toxicity, which can cause nausea, vomiting, weakness and kidney problems.
The NHS advises that everyone take a vitamin D supplement during the autumn and winter, as our body can't make enough of the nutrient - 10 micrograms is what's recommended.
But babies and children aged one to four need to take a daily supplement throughout the year, between 8.5 to 10 micrograms.
Key characteristics of autism
These are some features of autism that many people with it experience. Autism is a spectrum, so everyone shows symptoms differently.
Sensitive to senses
Autistic people can be much more or less sensitive than non-autistic people to the five main senses (sight, sound, touch, taste and smell).
This also extends to senses for balance, movement, spatial awareness and awareness of internal states, such as hunger and temperature.
Social differences
People with autism may find social interactions harder because they have difficulty; interpratiting social cues; facial expressions; maintaining eye contact; recognising sarcasm.
They may find tehy prefer to spend time alone because social interactions can be confusing.
Autism can be verbal (someone who uses communication) or non-verbal (they use other means to communicate). People can flit between the two.
Repetitive behaviours
'Restricted and repetitive behaviours and interests' is often listed as a trait of autism, but the National Autistic Society says many people with the condition actually find these behaviours as positive and helpful.
It is also sometimes referred to as stimming or self-regulatory behaviour.
Examples include having a strong passion or interest in a hobby, repeated behaviours like hair twirling or rocking, and preference for routine or rules to be followed.
Emotional dysregulation
People with autism may struggle to manage feelings such as frustration, anxiety, or sadness, which could lead to a 'meltdown' (extreme or intense outburst of emotions) or 'shutdown' (withdrawal).
Source:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Superbugs could kill millions more and cost $2tn a year by 2050, models show
Superbugs could kill millions more and cost $2tn a year by 2050, models show

The Guardian

time15 minutes ago

  • The Guardian

Superbugs could kill millions more and cost $2tn a year by 2050, models show

Superbugs could cause millions more people to die worldwide and cost the global economy just under $2tn a year by 2050, modelling shows. A UK government-funded study shows that without concerted action, increased rates of antimicrobial resistance (AMR) could lead to global annual GDP losses of $1.7tn over the next quarter of a century. The research, by the Center for Global Development thinktank, found the US, UK and EU economies would be among the hardest hit, prompting accusations that recent swingeing aid cuts are self-defeating. On Thursday, the UK government announced it was axing funding for the Fleming fund, which combats AMR in low- and middle-income countries, as part of wider aid cuts. The Trump administration has confirmed $9bn in cuts to its foreign aid budget, while a number of European countries have also reduced spending on overseas aid. Anthony McDonnell, the lead author and the research and a policy fellow at the Center for Global Development, said: 'When we conducted our research on the economic impacts of antimicrobial resistance, it was anticipated that resistance rates would continue to follow historical trends. 'However, the sudden cuts to Official Development Assistance by the US, which has cut its aid spend by roughly 80%; the UK, which has announced aid cuts from 0.5% to 0.3% of gross national income; and substantial reductions by France, Germany, and others, could drive up resistance rates in line with the most pessimistic scenario in our research. 'Even countries that have been successful in keeping AMR rates under control cannot afford to be complacent. Unless AMR programmes are protected from aid cuts, resistance rates across the world will likely increase at a rate in line with the worst-affected countries. 'This would result in millions more people dying worldwide, including across G7 nations. Investing in treatment for bacterial infections now will save lives and deliver billions in long-term economic returns.' The research calculated the economic and health burden of antibiotic resistance for 122 countries and forecast that in that in this most pessimistic scenario, by 2050, GDP losses in China could reach just under $722bn a year, the US $295.7bn, the EU $187bn, Japan $65.7bn and the UK $58.6bn. According to the Institute for Health Metrics and Evaluation (IHME), deaths from AMR are expected to increase 60% by 2050, with 1.34 million people in the US and 184,000 in the UK alone predicted to die each year from antibiotic resistant bugs, while numbers of those becoming seriously ill from drug-resistant bacteria are also expected to jump. Superbugs increase the number of hospital admissions and lead to longer and more intensive hospital stays, costlier second-line treatments and more complex care, meaning resistant infections are roughly twice as expensive to treat as those for which antibiotics are effective. The study estimates global health costs of treating AMR could increase by just under $176bn a year, while in the UK, they would rise from $900m to $3.7bn and in the US from $15.5bn to just under $57bn. Higher rates of resistant bugs would also shrink the UK, EU and US workforces by 0.8%, 0.6% and 0.4% respectively, the study found. But if countries invest more in tackling superbugs – increasing access to new antibiotics and high-quality treatment of these infections – the US economy would grow $156.2bn a year and the UK $12bn (£9.3bn) by 2050. Responding to the findings, Dr Mohsen Naghavi, a professor of health metrics at IHME, said: 'Today the threat of AMR is increasing, and without immediate action from all stakeholders the medicines we have access to now could stop working, potentially causing a simple infection to become deadly.' That would involve policy changes from the US, European and UK governments, the development of new drugs and ensuring everyone understood that antibiotics were ineffective against viruses, he added. A UK government spokesperson said: 'Our 10-year health plan recognises antimicrobial resistance (AMR) as a major threat and commits to urgently tackle its spread, including through new vaccines. 'We have made important progress - reducing antibiotic use in meat and pioneering a world-first subscription model to incentivise the development of new treatments. We also continue to work closely with international partners to influence global efforts to limit the spread of AMR.'

The Guardian view on mitochondrial donation: IVF innovation leads to a cautious genetic triumph
The Guardian view on mitochondrial donation: IVF innovation leads to a cautious genetic triumph

The Guardian

timean hour ago

  • The Guardian

The Guardian view on mitochondrial donation: IVF innovation leads to a cautious genetic triumph

Eight babies have been born free of a disease that can lead to terrible suffering and early death, thanks to pioneering scientists in the UK employing a form of genetic engineering that is banned in some countries, including the US and France. Ten years ago, when the government and regulators were considering whether to allow mitochondrial transfer technology, critics warned of 'Frankenstein meddling' that would lead to three-parent children. It's hard now to justify such hostility in the face of the painstaking work carried out by the scientific and medical teams at Newcastle, resulting in these healthy babies and ecstatic families. Mitochondria, like tiny battery packs, supply energy to every cell of the body. Their DNA is handed down in the egg from mother to child. In rare instances, there are genetic mutations, which means the baby may develop mitochondrial disease. About one in 5,000 people is affected by it, making it one of the most common inherited disorders. As the cell batteries fail in various organs, the child can experience a range of symptoms, from muscle weakness to epilepsy, encephalopathy, blindness, hearing loss and diabetes. In severe cases, they die young. There is no cure yet, so the aim is prevention. Women who have some damaged and some healthy mitochondria can have IVF and pre-implantation genetic testing (PGT) to select embryos that are clear of mutations or only slightly affected. The options for women with 100% mutated mitochondria used to be limited to donated eggs or adoption – until parliament changed the rules to allow the technology in 2015 and the Newcastle Fertility Centre was granted a licence by the Human Fertilisation and Embryology Authority to use it in 2017. The process does indeed involve three people. The would-be mother's egg and a donor egg are both fertilised by the man's sperm. The nucleus of the donated egg is removed and replaced by the nucleus of the woman's egg, but its healthy mitochondria remain. This composite egg is inserted into the woman's uterus. The resulting baby's DNA will be 99.9% from the parents and only 0.1% from the donor. Hardly a three-parent child. Yet there are controversies. Some countries will not permit use of the technology because of concerns over human germline genetic modification. The lab-mixed DNA will be passed to future generations, with who knows what consequences. And a question hangs over something called reversal, or reversion. The results of the Newcastle research published in the New England Journal of Medicine show that some of the embryos with healthy donated mitochondria developed mutations somewhere along the line. Mutations formed in 12% of one baby's mitochondria and 16% in another's. That was not enough to affect the babies, who were healthy, but previous work by other scientists has suggested that mutations can increase with time, and nobody yet understands why. The Newcastle scientists and medics have been highly praised for their slow and methodical work. They have brought joy to some families and hope to others. But this is still experimental technology and caution is absolutely valid. And inevitably there are cost issues. People who can afford it will no doubt pay, but the NHS is unlikely to be able to help the rest. Nonetheless, this groundbreaking research must surely be allowed to continue, albeit only in the same careful fashion.

At 82, I'm completely at home with bacteria
At 82, I'm completely at home with bacteria

The Guardian

timean hour ago

  • The Guardian

At 82, I'm completely at home with bacteria

Regarding the article on bacteria in homes (Is your home a health hazard? 15 surprisingly filthy everyday items, from taps to toothbrushes, 17 July), I have managed to live to the age of 82 without ever putting a cutting board in the dishwasher, or sterilising light switches, the TV remote or my spectacles. I do boil the dishcloth every couple of weeks and that's it. We have lived with these bacteria for millennia. Is there any evidence that sterilising every surface would do anything other than increase paranoia?Owen WellsIlkley, West Yorkshire Adrian Chiles, trying to sleep in the heat of the Croatian summer, should use a canny old Australian trick: keep your pyjamas in the freezer until bedtime (I've found the cure for a sleepless night in a heatwave – but it can have its drawbacks…, 17 July). Bliss!Liz TaylorWest Bridgford, Nottinghamshire To answer Tony Meacock's question (Letters, 18 July), no, I haven't finished my replica of the Bayeux tapestry yet. Right now, the completed embroidery stands at 52.6 metres. I aim to finish in HanssonWisbech, Cambridgeshire Wow! Blake Morrison's compilation of terrorists (Letters, 18 July) is the most powerful letter I have ever seen in my 60 years of reading the Guardian. I just hope that those who could make a difference will read it. Gill Empson Edwinstowe, Nottinghamshire Thanks to Blake Morrison for his poem. It just reminded me why I buy the KinderRomsey, Hampshire Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store